REXLABAC

Serial Number 90752761
606

Registration Progress

Application Filed
Jun 3, 2021
Under Examination
Apr 26, 2022
Approved for Publication
Mar 1, 2022
Published for Opposition
Mar 1, 2022
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: REXLABAC
Previous Owner: Azurity Pharmaceuticals, Inc.
Classes: 005

Trademark Image

REXLABAC

Basic Information

Serial Number
90752761
Filing Date
June 3, 2021
Published for Opposition
March 1, 2022
Abandonment Date
October 15, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Oct 15, 2025
Classes
005

Rights Holder

Azurity Pharmaceuticals, Inc.

03
Address
8 Cabot Road, Suite 2000
Woburn, MA 01801

Ownership History

Azurity Pharmaceuticals, Inc.

Original Applicant
03
Woburn, MA

Azurity Pharmaceuticals, Inc.

Owner at Publication
03
Woburn, MA

Legal Representation

Attorney
Douglas R. Wolf

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

36 events
Date Code Type Description Documents
Oct 15, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Oct 15, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 27, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 27, 2024 EX5G S SOU EXTENSION 5 GRANTED Loading...
Aug 27, 2024 EXT5 S SOU EXTENSION 5 FILED Loading...
Aug 27, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 5, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 4, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Mar 4, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Mar 4, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Aug 31, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 29, 2023 EX3G S SOU EXTENSION 3 GRANTED Loading...
Aug 29, 2023 EXT3 S SOU EXTENSION 3 FILED Loading...
Aug 29, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 7, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Mar 3, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Mar 3, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Mar 3, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Sep 2, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Aug 31, 2022 EX1G S SOU EXTENSION 1 GRANTED Loading...
Aug 31, 2022 EXT1 S SOU EXTENSION 1 FILED Loading...
Aug 31, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 26, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 1, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 1, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 9, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Jan 26, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jan 25, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Jan 24, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Jan 24, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jan 12, 2022 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2022 GNRT F NON-FINAL ACTION E-MAILED Loading...
Jan 12, 2022 CNRT R NON-FINAL ACTION WRITTEN Loading...
Jan 7, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 26, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 7, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of spasticity resulting from multiple sclerosis, including relief of flexor spasms, concomitant pain, clonus, and muscular rigidity; pain relief medication

Classification

International Classes
005